Optimizing Particle Size of pH Modifiers Enhances Dissolution of Weakly Basic Drugs

AAPS PharmSciTech. 2026 Apr 18;27(4):182. doi: 10.1208/s12249-026-03418-2.

Abstract

Objective: This study aimed to investigate the pH-dependent dissolution of the weakly basic drug carvedilol (BCS Class II) and systematically examine the influence of citric acid concentration and particle size on its release.

Methods: A series of dissolution studies was conducted in media simulating the gastrointestinal pH range (1.2-7.8), specifically evaluating the effects of citric acid concentration (3% and 9%) and particle size (fine Dv50 44 μm vs. coarse Dv50 608 μm).

Results: Under acidic conditions (pH 1.2-1.6), carvedilol solubility was high and the effect of citric acid particle size was negligible (<1.3% difference). In the mid-pH range (3.8-6.5), fine citric acid particles rapidly created an acidic microenvironment (pH 3.5±0.2), enhancing carvedilol solubility 2.1-2.8-fold and improving dissolution by 3.1-15.7% compared to coarse particles; increasing the citric acid concentration from 3% to 9% reduced this particle size-dependent variability. At high pH (6.8-7.8), the effect of citric acid weakened, though coarse particles still prolonged acid release.

Conclusion: While citric acid concentration universally enhanced carvedilol dissolution, the effect of its particle size was pH-dependent, being negligible at low pH but pronounced at higher pH, where larger particles sustained drug release more effectively.

Keywords: Carvedilol; Citric acid; PH microenvironment; Particle size; Weakly alkaline drug.

MeSH terms

  • Carbazoles* / chemistry
  • Carvedilol / chemistry
  • Chemistry, Pharmaceutical / methods
  • Citric Acid* / chemistry
  • Drug Liberation
  • Hydrogen-Ion Concentration
  • Particle Size
  • Propanolamines* / chemistry
  • Solubility

Substances

  • Carvedilol
  • Citric Acid
  • Propanolamines
  • Carbazoles